Cargando…
Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
BACKGROUND AND PURPOSE: Abundant studies have shown that lncRNA PANDAR plays an oncogenic role in human solid tumors. Although abnormal expression of PANDAR has been well investigated in solid tumors, it was rarely studied in hematologic diseases. Hence, the aim of this study was to determine the PA...
Autores principales: | Yang, Lan, Zhou, Jing-Dong, Zhang, Ting-Juan, Ma, Ji-Chun, Xiao, Gao-Fei, Chen, Qin, Deng, Zhao-Qun, Lin, Jiang, Qian, Jun, Yao, Dong-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214337/ https://www.ncbi.nlm.nih.gov/pubmed/30464600 http://dx.doi.org/10.2147/CMAR.S180150 |
Ejemplares similares
-
Regulatory roles of lncRNA PANDAR in breast cancer cell proliferation
por: Sun, Qinnuan, et al.
Publicado: (2021) -
KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017) -
LncRNA-PANDAR regulates the progression of thyroid carcinoma by targeting miR-637/KLK4
por: Qing, Yi, et al.
Publicado: (2021) -
LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression
por: Sang, Yi, et al.
Publicado: (2016) -
Knockdown of lncRNA-PANDAR suppresses the proliferation, cell cycle and promotes apoptosis in thyroid cancer cells
por: Li, Zhirong, et al.
Publicado: (2017)